🇺🇸 Duanorubicin in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 10
Most-reported reactions
- Blood Pressure Decreased — 1 report (10%)
- Catheter Site Erythema — 1 report (10%)
- Catheter Site Pain — 1 report (10%)
- Catheter Site Related Reaction — 1 report (10%)
- Depressed Level Of Consciousness — 1 report (10%)
- Drug Toxicity — 1 report (10%)
- Dyspnoea — 1 report (10%)
- Ecchymosis — 1 report (10%)
- Haematemesis — 1 report (10%)
- Haemoptysis — 1 report (10%)
Other Other approved in United States
Frequently asked questions
Is Duanorubicin approved in United States?
Duanorubicin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Duanorubicin in United States?
Arog Pharmaceuticals, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.